Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
hyperCORE International operates one of the world’s largest networks of independent clinical research sites. It enables and accelerates Phase I–IV clinical trials for pharmaceutical and biotechnology companies by providing centralized access to over 125 active sites across two continents and five countries. The alliance has supported more than 7,000 studies involving over 140,000 patients and thousands of investigational treatments. Its focus includes decentralized (direct-to-patient) trial models to improve patient access and retention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on hyperCORE International.